Biotech Values

[kaivamei]

Rstor1: ONCY

+++When I asked the CEO about the delay with the US trial, he said that the FDA wanted to wait for definitive safety results from the HC trial before giving the go-ahead (which came a couple of weeks ago.)+++

Interesting: so it was essentially the worst case regulatory scenario, albeit now drawn to a close. Of course, the silver lining is the assurance now provided that the HC safety data is positive.

I wonder if this means that the Canadian results could be in such shape that they might actually be released soon?

When you spoke to BT, did you get a meaningful response to the question about whether glio enrollment is complete?

What else did you learn from Dr. T?

(Email me privately if that would be more appropriate.)

Thanks,

-kaiva